Induction of UBQLN1 ‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells
BioFactors · 2025
DOI: 10.1002/biof.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Xuefen Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Liver Neoplasms, Autophagy-Related Proteins, Drug Resistance, Neoplasm, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Nanjing University of Chinese Medicine.
Abstract (Originalsprache)
Hypoxia is a key reason for the failure of liver cancer therapy. Emerging evidences indicated that ROS played a crucial role in the sorafenib therapy, and overcoming the reduction in intracellular ROS levels was the first requirement for therapy resistance. Ubiquilin1 (UBQLN1) acted as an oncogene or suppressor gene involved in the protein degradation and abnormal protein aggregation. In this study, we proposed a novel strategy to reverse the hypoxia‐induced resistance in liver cancer by isoliensinine (Iso), a significant bioactive compound derived from lotus seed. Based on preliminary screening, we found a significant elevation of UBQLN1 in liver cancer tissues obtained from the TCGA databases and in liver cancer cells under hypoxic model, which contributed to hypoxia‐induced sorafenib resistance. Further data suggested that Iso significantly reversed the hypoxia‐induced sorafenib resistance through directly targeting UBQLN1 and inducing ROS production. Notably, the ROS elevation induced by Iso could trigger IRP2‐induced ferroptosis but remained below the threshold for mitochondrial damage in liver cancer cells. The related mechanism was that Iso reduced the binding between PGC1α and ubiquitin, promoting the stability of the PGC1α protein, which might accelerate mitochondrial energy metabolism. Taken together, our findings not only revealed that UBQLN1 played a critical role in ROS regulation, but also uncovered a previously unrecognized reversal mechanism of Iso in liver cancer, which promoted sensitization of sorafenib‐induced ferroptosis by inhibition of UBQLN1/PGC1α pathway under hypoxia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China.
- Jangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
- Institute of Traditional Chinese Medicine (TCM)-Related Comorbid Depression, School of Chinese Medicine & School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Repu…
- Department of Anesthesiology, The Second Hospital of Nanjing, Nanjing, Jiangsu, People's Republic of China.
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, People's Republic of China.
ORCID-Profile: Xuefen Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Nanjing University of Chinese Medicine
Zitieren
APA
Xu, X., Li, W., Zhou, Y., Wang, M., Ji, S., Xia, S., Li, Y., Guo, X., Huan, S., Wang, F., Zhang, F., Cheng, H., Yin, G., & Zheng, S. (2025). Induction of UBQLN1 ‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells. BioFactors. https://doi.org/10.1002/biof.70008
Vancouver
Xu X, Li W, Zhou Y, Wang M, Ji S, Xia S, et al. Induction of UBQLN1 ‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells. BioFactors. 2025. doi:10.1002/biof.70008
BibTeX
@article{Xu2025,
author = {Xu, Xuefen and Li, Wei and Zhou, Ya and Wang, Meihui and Ji, Shufan and Xia, Siwei and Li, Yang and Guo, Xiaohan and Huan, Sheng and Wang, Feixia and Zhang, Feng and Cheng, Haibo and Yin, Guoping and Zheng, Shizhong},
title = {Induction of UBQLN1 ‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells},
journal = {BioFactors},
year = {2025},
doi = {10.1002/biof.70008}
}
EUVIMED